Oncotarget | Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma
December 13, 2022
PRESS RELEASE: A new research paper was published in Oncotarget's Volume 13 on August 16, 2022, entitled, “Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma.” continue reading »